Primary Prevention of Sudden Cardiac Death in Asia

Affiliations

¹ Cardiology Division, Department of Medicine, School of Clinical Medicine, Queen Mary Hospital, the University of Hong Kong, Hong Kong SAR, China. Electronic address: cplau@hku.hk.
² Cardiology Division, Department of Medicine, School of Clinical Medicine, Queen Mary Hospital, the University of Hong Kong, Hong Kong SAR, China; Cardiac and Vascular Center, the University of Hong Kong Shenzhen Hospital, Shenzhen, China; Centre for Stem Cell Translational Biology, Hong Kong SAR, China.

Editorial

Chu-Pak Lau et al. JACC Asia. 2023.

. 2023 Jun 6;3(3):346-348.

doi: 10.1016/j.jacasi.2023.04.006. eCollection 2023 Jun.

¹ Cardiology Division, Department of Medicine, School of Clinical Medicine, Queen Mary Hospital, the University of Hong Kong, Hong Kong SAR, China. Electronic address: cplau@hku.hk.
² Cardiology Division, Department of Medicine, School of Clinical Medicine, Queen Mary Hospital, the University of Hong Kong, Hong Kong SAR, China; Cardiac and Vascular Center, the University of Hong Kong Shenzhen Hospital, Shenzhen, China; Centre for Stem Cell Translational Biology, Hong Kong SAR, China.

No abstract available

Keywords: Asia; ICD; defibrillator; implantable cardioverter-defibrillator; primary prevention; sudden cardiac death.

Conflict of interest statement

The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Use of Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death in Asia.
Ueda N, Noda T, Kusano K, Yasuda S, Kurita T, Shimizu W. Ueda N, et al. JACC Asia. 2023 Apr 25;3(3):335-345. doi: 10.1016/j.jacasi.2023.02.004. eCollection 2023 Jun. JACC Asia. 2023. PMID: 37323866 Free PMC article. Review.

1. Hayashi M., Shimizu W., Albert C.M. The spectrum of epidemiology underlying sudden cardiac death. Circ Res. 2015;116:1887–1906. - PMC - PubMed
1. McMurray J.J., Packer M., Desai A.S., et al. PARADIGM-HF Investigators and Committees Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993–1004. - PubMed
1. Younis A., Wilkoff B.L. Implantable cardioverter-defibrillator for primary prevention in Asia. JACC: Asia. 2023;3:321–334. - PMC - PubMed
1. Ueda N., Noda T., Kusano K., Yasuda S., Kurita T., Shimizu W. Use of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in Asia. JACC: Asia. 2023;3:335–345. - PMC - PubMed
1. Yancy C.W., Jessup M., Bozkurt B., et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017;70:776–803. - PubMed